Analyst Group: Analyst Group Comment on Nosa Plugs Q4-report
On February 14, 2025, Nosa Plugs published the company’s interim report for the fourth quarter of 2024.
To summarize, Analyst Group considers Nosa Plugs to have delivered a strong report that was largely in line with our expectations, although delays in Australia and weaker-than-expected development in the UK slightly impacted sales. However, the gross margin was robust, and in combination with strong cost control, earnings met our expectations. We see strong prospects for continued growth in 2025, with investments in Odor Control and Smell Training expected to yield results, alongside the launch of a new product, NOSA Nozoil. Additionally, we look forward to updates regarding Drug Delivery throughout the year.
Read our comment on the report here
Sammantaget anser Analyst Group att Nosa Plugs levererade en stark rapport som i stort var i linje med våra förväntningar, även om förseningar i Australien och svagare utveckling än väntat i Storbritannien påverkade försäljningen något. Däremot var bruttomarginalen stark och i kombination med en stark kostnadskontroll uppnåddes våra förväntningar på resultatet. Vi ser goda förutsättningar att fortsätta tillväxtresan under år 2025, där satsningar på Odor Control och Smell Training förväntas bära frukt samt att en ny produkt i form av NOSA Nozoil har lanserats. Därtill ser vi fram emot uppdateringar gällande Drug Delivery under året.
Läs Analyst Groups rapportkommentar här
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.